| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11892-005-0034-Z |
| P698 | PubMed publication ID | 15794910 |
| P2093 | author name string | George L King | |
| Zhiheng He | |||
| Yizhen Xu | |||
| P2860 | cites work | Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells | Q24301972 |
| Role of oxidative stress in diabetic complications: a new perspective on an old paradigm | Q77804864 | ||
| Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus | Q78040840 | ||
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
| The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 | ||
| Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
| Expression of glutamine:fructose-6-phosphate amidotransferase in human tissues: evidence for high variability and distinct regulation in diabetes | Q28265750 | ||
| Tumor necrosis factor-alpha in diabetic plasma increases the activity of core 2 GlcNAc-T and adherence of human leukocytes to retinal endothelial cells: significance of core 2 GlcNAc-T in diabetic retinopathy | Q28289690 | ||
| Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site | Q28363492 | ||
| N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression | Q28645594 | ||
| Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy | Q29012485 | ||
| Innate immunity | Q29618949 | ||
| Identification of PKC-isoform-specific biological actions using pharmacological approaches | Q33901025 | ||
| Oxidant stress in the vasculature | Q34107235 | ||
| Lipid disorders in type 1 and type 2 diabetes. | Q34231407 | ||
| Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond | Q34282992 | ||
| Insulin action in the vasculature: physiology and pathophysiology | Q34372203 | ||
| Oxidative stress and diabetic vascular complications | Q34391178 | ||
| Protein kinase C and the development of diabetic vascular complications | Q34570516 | ||
| Diabetes and atherosclerosis: epidemiology, pathophysiology, and management | Q34646074 | ||
| Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat | Q34762247 | ||
| The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance | Q34984896 | ||
| Molecular understanding of hyperglycemia's adverse effects for diabetic complications | Q35005662 | ||
| Endothelium, inflammation, and diabetes | Q35087609 | ||
| Impact and mechanism for oxidized and glycated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells | Q35169109 | ||
| Oxidative stress: the lead or supporting actor in the pathogenesis of diabetic complications | Q35182343 | ||
| Role of lipids in chemical modification of proteins and development of complications in diabetes | Q35594328 | ||
| Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes | Q35677410 | ||
| Microvascular complications of diabetes | Q35725856 | ||
| Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency | Q35788419 | ||
| Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. | Q35860982 | ||
| Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease | Q35988237 | ||
| Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance | Q36002036 | ||
| Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus | Q37239783 | ||
| Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy | Q37318352 | ||
| Glutamine:fructose-6-phosphate amidotransferase activity in cultured human skeletal muscle cells: relationship to glucose disposal rate in control and non-insulin-dependent diabetes mellitus subjects and regulation by glucose and insulin | Q37352518 | ||
| Role of the glucosamine pathway in fat-induced insulin resistance | Q37366568 | ||
| Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
| Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy | Q37653146 | ||
| Increased activity of the hexosamine synthesis pathway in muscles of insulin-resistant ob/ob mice | Q38345334 | ||
| High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells | Q39796701 | ||
| Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system | Q40668935 | ||
| Management of dyslipidemia in IDDM patients | Q40748883 | ||
| Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179). | Q40799734 | ||
| Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts | Q41009444 | ||
| Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance | Q41179543 | ||
| Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. | Q41893958 | ||
| RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy | Q42263637 | ||
| Endothelial dysfunction: its relationship with acute hyperglycaemia and hyperlipidemia | Q42524586 | ||
| Flux through the hexosamine pathway is a determinant of nuclear factor kappaB- dependent promoter activation | Q43935477 | ||
| RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response | Q44032299 | ||
| The association of hyperlipidemia with retinopathy in diabetic patients aged 15-50 years in the county of Umeå. | Q44098033 | ||
| Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis | Q44121998 | ||
| Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy | Q44195306 | ||
| High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species | Q44324621 | ||
| P38 mitogen-activated protein kinase mediates hexosamine-induced TGFbeta1 mRNA expression in human mesangial cells | Q44393197 | ||
| Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study | Q44495277 | ||
| Protein kinase Cbeta selective inhibitor LY333531 attenuates diabetic hyperalgesia through ameliorating cGMP level of dorsal root ganglion neurons | Q44527071 | ||
| Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy | Q44544991 | ||
| Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus | Q44553205 | ||
| Activation of the innate immune system as a predictor of cardiovascular mortality in Type 2 diabetes mellitus | Q44553379 | ||
| Glycemic control, oxidative stress, and lipid profile in children with type 1 diabetes mellitus | Q44792656 | ||
| Chronic complications and risk factors in patients with type 1 diabetes mellitus--retrospective analysis | Q44825352 | ||
| F2 isoprostane is already increased at the onset of type 1 diabetes mellitus: effect of glycemic control | Q45034780 | ||
| G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells | Q47283265 | ||
| Is type II diabetes mellitus a disease of the innate immune system? | Q48364597 | ||
| Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy. | Q50988567 | ||
| Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM. | Q51582714 | ||
| Glycation of lipoproteins and accelerated atherosclerosis in non-insulin-dependent diabetes mellitus. | Q51591614 | ||
| Increased O-GlcNAc transferase in pancreas of rats with streptozotocin-induced diabetes. | Q54029898 | ||
| Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin. | Q54062879 | ||
| Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study | Q57830053 | ||
| Evidence for control of tumour necrosis factor-alpha (TNF-alpha) activity by TNF receptors in patients with proliferative diabetic retinopathy | Q63407527 | ||
| High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells | Q73010828 | ||
| A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats | Q73060971 | ||
| Vitamin E supplementation and cardiovascular events in high-risk patients | Q73365511 | ||
| Glycated lipoprotein and atherosclerosis | Q73423162 | ||
| Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes | Q73502161 | ||
| Homocysteine and oxidized low density lipoprotein enhanced platelet adhesion to endothelial cells under flow conditions: distinct mechanisms of thrombogenic modulation | Q73597860 | ||
| Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor | Q73674093 | ||
| d-alpha-tocopherol treatment prevents glomerular dysfunctions in diabetic rats through inhibition of protein kinase C-diacylglycerol pathway | Q74382209 | ||
| P433 | issue | 2 | |
| P921 | main subject | hyperglycemia | Q271993 |
| dyslipidemia | Q66291209 | ||
| P304 | page(s) | 91-97 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Current diabetes report | Q26841965 |
| P1476 | title | Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications | |
| P478 | volume | 5 |
| Q37386964 | Antidiabetic effects of Mangifera indica Kernel Flour-supplemented diet in streptozotocin-induced type 2 diabetes in rats |
| Q37340468 | Endothelial inflammation induced by excess glucose is associated with cytosolic glucose 6-phosphate but not increased mitochondrial respiration |
| Q30358451 | Formation of methionine sulfoxide during glycoxidation and lipoxidation of ribonuclease A. |
| Q36457460 | Green Tea Attenuates Oxidative Stress and Downregulates the Expression of Angiotensin II AT(1) Receptor in Renal and Hepatic Tissues of Streptozotocin-Induced Diabetic Rats |
| Q37615975 | High glucose induces human endothelial dysfunction through an Axl-dependent mechanism |
| Q36571337 | Hypolipidemic Activity of Chloroform Extract of Mimosa pudica Leaves. |
| Q60044836 | Phytochemical analysis and antidiabetic potential of Elaeagnus umbellata (Thunb.) in streptozotocin-induced diabetic rats: pharmacological and computational approach |
| Q95261029 | Proteomic analysis of oxidative stress response in human umbilical vein endothelial cells (HUVECs): role of heme oxygenase 1 (HMOX1) in hypoxanthine-induced oxidative stress in HUVECs |
| Q27647754 | Structure-based design of robust glucose biosensors using aThermotoga maritimaperiplasmic glucose-binding protein |
Search more.